StonvexLoading…
StonvexStonvexStonvexCore line items from AIZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.42B | $12.81B | $9.46B | $6.23B |
Operating Income | $335.60M | $1.09B | $803.90M | $472.70M |
Net Income | $274.10M | $872.70M | $647.50M | $381.90M |
EPS (Diluted) | $5.41 | $16.93 | $12.55 | $7.38 |
Total Assets | $35.77B | $36.29B | $35.78B | $35.53B |
Total Liabilities | $29.90B | $30.42B | $30.02B | $30.03B |
Cash & Equivalents | $1.59B | $1.83B | $1.71B | $1.49B |
Free Cash Flow OCF − CapEx | $192.60M | $1.60B | $986.70M | $544.60M |
Shares Outstanding | 49.67M | 49.79M | 50.20M | 50.53M |